1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Anca Vasculitis Global Clinical Trials Review, H2, 2014

Anca Vasculitis Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 68 pages

Anca Vasculitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Anca Vasculitis Global Clinical Trials Review, H2, 2014" provides data on the Anca Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anca Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anca Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Anca Vasculitis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Anca Vasculitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Anca Vasculitis to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Anca Vasculitis to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Anca Vasculitis 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Anca Vasculitis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
ChemoCentryx, Inc. 32
Clinical Trial Overview of ChemoCentryx, Inc. 32
Anthera Pharmaceuticals‚ Inc. 33
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 33
Clinical Trial Overview of Top Institutes / Government 34
Assistance Publique - Hopitaux de Paris 34
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 34
Ministry of Health, Labour and Welfare, Japan 35
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 35
Cambridge University Hospitals NHS Foundation Trust 36
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 36
University of Pennsylvania 37
Clinical Trial Overview of University of Pennsylvania 37
University of Oxford 38
Clinical Trial Overview of University of Oxford 38
Mayo Clinic 39
Clinical Trial Overview of Mayo Clinic 39
University Hospitals Birmingham NHS Foundation Trust 40
Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust 40
Shanghai Jiao Tong University 41
Clinical Trial Overview of Shanghai Jiao Tong University 41
University of Schleswig-Holstein 42
Clinical Trial Overview of University of Schleswig-Holstein 42
University of Edinburgh 43
Clinical Trial Overview of University of Edinburgh 43
Five Key Clinical Profiles 44
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables
Anca Vasculitis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Anca Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anca Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Anca Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Anca Vasculitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Anca Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Anca Vasculitis to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Anca Vasculitis to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Anca Vasculitis Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Anca Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Anca Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Anca Vasculitis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Anca Vasculitis Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Anca Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Anca Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Anca Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Anca Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Anca Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 31
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2014* 32
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2014* 33
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 34
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2014* 35
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2014* 36
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 37
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 38
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 39
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2014* 40
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2014* 41
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2014* 42
Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014* 43

List of Figures
Anca Vasculitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Anca Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Anca Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Anca Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Anca Vasculitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Anca Vasculitis to Immunology Clinical Trials, G7 Countries (%), 2014* 14
Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Anca Vasculitis to Immunology Clinical Trials, E7 Countries (%), 2014* 17
Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Anca Vasculitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Anca Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Anca Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Anca Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Anca Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Anca Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Anca Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Anca Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 67

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.